Sign In
Buy PETV
$0.726
+0.0557 (+8.31%)
At Close: Jun 03, 2026
PetVivo Reports Fiscal Q2 2025 Results
04:00pm, Thursday, 14'th Nov 2024
MINNEAPOLIS, MN, US, Nov. 14, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and compa
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE SECOND QUARTER ENDED SEPTEMBER 30, 2024
10:07am, Monday, 11'th Nov 2024
MINNEAPOLIS, MN, US, Nov. 11, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical ther
MINNEAPOLIS, MN, Oct. 21, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Cindy Gil
AMI continues to expand its media portfolio by adding programmable Taxi Tops and multiple billboards in Las Vegas, ensuring unmatched exposure for its clients. NEW YORK, NY / ACCESSWIRE / October 13,
Expert Capablites of Senior Vet-Tech to Help Drive Greater Adoption of Spryng as Breakthrough Treatment of Osteoarthritis for Companiaon Animals
ASLAN Pharmaceuticals Limited; Conn's, Inc.; 2U, Inc.; International Media Acquisition Corp.; Presto Automation, Inc.; and VBI Vaccines, Inc.; from The Nasdaq Stock Market ASLAN Pharmaceuticals Limi
Scot Cave Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager
10:27am, Tuesday, 03'rd Sep 2024
MINNEAPOLIS, MN, US, Sept. 03, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovativ
Anthony Germinaro Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager
10:10am, Monday, 19'th Aug 2024
MINNEAPOLIS, MN, US, Aug. 19, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCB: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative
PetVivo Holdings, Inc. (PETV) Q1 2025 Earnings Call Transcript
09:44pm, Wednesday, 14'th Aug 2024
PetVivo Holdings, Inc. (OTCPK:PETV) Q1 2025 Earnings Call August 14, 2024 5:00 PM ET Company Participants John Dolan - Chief Business Development Officer and General Counsel John Lai - Chief Executive
PetVivo Reports Reports Fiscal Q1 2025 Results
04:25pm, Wednesday, 14'th Aug 2024
Company Reieterates Gudience of 50% to 100% Revenue Growth in Fiscal 2025 MINNEAPOLIS, MN, US, Aug. 14, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading biomedical compa
Eric Samples Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager
01:52pm, Monday, 12'th Aug 2024
MINNEAPOLIS, MN, US, Aug. 12, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative
PetVivo Sets Fiscal First Quarter 2025 Conference Call for Wednesday, August 14 at 5:00 p.m. ET
10:25am, Thursday, 08'th Aug 2024
MINNEAPOLIS, MN, US, Aug. 08, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and compa
PetVivo Reports Reports Fiscal 2024 Results
04:41pm, Friday, 28'th Jun 2024
MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and compani
PetVivo Sets Fiscal Fourth Quarter 2024 Conference Call for Friday, June 28 at 5:00 p.m. ET
04:15pm, Tuesday, 25'th Jun 2024
MINNEAPOLIS, MN, US, June 25, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and compani
PetVivo Appoints Former NOVUS and Colgate-Palmolive Senior Sales & Marketing Executive, Bryan Monninger, as VP of Sales
07:00am, Thursday, 06'th Jun 2024
MINNEAPOLIS, MN, US, June 06, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and compani
